EKSO BIONICS HOLDINGS INC (NASDAQ:EKSO) Reports Q2 2025 Earnings: Revenue Misses, Narrower Loss Than Expected

EKSO BIONICS HOLDINGS INC (NASDAQ:EKSO) reported its second-quarter 2025 financial results, missing revenue estimates but delivering a narrower-than-expected loss per share. The company’s performance and market reaction reflect the challenges and cautious optimism surrounding its exoskeleton technology business.

Key Financial Results vs. Estimates

• Revenue: Reported $2.06 million, significantly below analyst expectations of $4.4 million.
• Earnings Per Share (EPS): Posted a loss of $1.24 per share, better than the estimated loss of $1.377.

The revenue shortfall suggests weaker-than-anticipated sales in both its medical and industrial exoskeleton segments. However, the smaller-than-expected loss indicates some progress in cost management or operational efficiency.

Market Reaction

Following the earnings release, EKSO shares declined nearly 2.9% in after-hours trading. This immediate reaction suggests investor disappointment with the revenue miss, despite the EPS beat. Over the past month, the stock had gained 35%, possibly reflecting pre-earnings optimism or broader sector momentum. The post-earnings dip indicates that revenue performance remains a critical concern for shareholders.

Analyst Estimates for Future Performance

Looking ahead, analysts project:

• Q3 2025 Revenue: $4.23 million
• Q3 2025 EPS: -$1.45
• Full-Year 2025 Revenue: $17.96 million
• Full-Year 2025 EPS: -$5.51

These estimates suggest continued losses but with expectations of gradual revenue growth. The lack of an explicit outlook in the press release means investors must rely on these projections while monitoring execution risks.

Press Release Highlights

The earnings announcement emphasized EKSO’s position as a leader in medical and industrial exoskeleton technology. However, no specific forward-looking guidance was provided, leaving investors to assess performance based on historical trends and analyst models.

For a deeper dive into EKSO’s earnings history and future estimates, see the earnings and estimates page.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a financial advisor before making decisions.